Stem cell and transplantation resources for researchers and patients
Official title: Stem Cell and Transplantation Biology
Funded at Fred Hutchinson Cancer Center · NIH-11530324 · Data updated 2026-11-12
A national program provides researchers with access to large numbers of human stem cells, viral vectors, and gene-editing tools to advance blood disease research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 1, 2015 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $877,378 |
| NIH project number | 5U54DK106829-12 |
| Project ID | NIH-11530324 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with blood diseases who may participate indirectly by contributing samples or enrolling in future trials following the development of therapies arising from this research.
✕Less likely to help
Patients not directly involved in this core research project may not experience immediate benefits.
What this research studies
This grant funds core services that help scientists study blood diseases by supplying human stem/progenitor cells, scalable viral production for several gene therapy vectors, and gene-editing products. It also includes training on best practices, quality control, and standard operating procedures to ensure safe, high-quality work. The goal is to expand access to these resources across the United States so that more investigators can pursue advances that may eventually benefit patients with blood disorders.
Why it matters
Potential benefit: If successful, patients with blood diseases could benefit from faster development of cell-based therapies and better understanding of their conditions through improved research infrastructure.
How similar studies have gone: Previous iterations have shipped purified CD34 cells and established cost-effective, high-quality resources, suggesting a promising track record for similar efforts.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Stirewalt, Derek L — Fred Hutchinson Cancer Center
- Study coordinator: Stirewalt, Derek L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.